Cardiovascular Systems

Selected news for the company - Cardiovascular Systems, collected since 10/2017. Recent stories appear in cmlviz.com and zolmax.com. This company shares news with Medtronic, Boston Scientific, Terumo and many others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
4/8/2021 Other news to note for April 8, 2021 | 08 BioWorld Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acornmed, Al Zahrawi Medical Supplies, Aumet Construction & Hospitals Management, Cardiovascular Systems , Carepics, Ceapro, Distribuidora Indexlab, EMD Serono, Emids, Exechealth, Ibex Medical Analytics, Invitae, Ischemaview, Magellan Rx Management, Merck, Mintcare, Moleculight, Nanomedix, Pelvalon, Philips, PRA Health Sciences, Quovantis Technologies, Rapidai, Renalytix AI, Sedeer Medical, Sightcall, Stago, Tradis Gat, Trapelo Health, Well Health Technologies ...
3/24/2021 Comparing DexCom (NASDAQ:DXCM) & Cardiovascular Systems (NASDAQ:CSII) baseballnewssource.com 0 3.00DexCom presently has a consensus target price of $443.07, indicating a potential upside of 21.66%. Cardiovascular Systems has a consensus target price of $47.57, indicating a potential upside of 20.71%. Given DexCom’s higher probable upside, analysts clearly believe DexCom is more favorable than Cardiovascular Systems.SummaryDexCom beats Cardiovascular Systems on 11 of the 14 factors compared between the two stocks.About DexComDexCom, Inc., a medical ...
3/24/2021 Needham Releases a Buy Rating on NeoGenomics (NEO) markets.co ... a Buy rating to NeoGenomics ( NEO – Research Report ), with a price target of $65.00 $48.13. Matson is a 5-star 15.9% and a 69.3% success rate. Matson covers the Healthcare Axonics Modulation Technologies, Cardiovascular Systems , and Zimmer Biomet Holdings.The word on The Street in general, suggests a Strong Buy analyst consensus rating for NeoGenomics with a $63.57 averageNeoGenomics’ market cap is currently $5.7B and has a ...
3/22/2021 Reviewing DexCom (NASDAQ:DXCM) & Cardiovascular Systems (NASDAQ:CSII) theenterpriseleader.com 1.84 187.30DexCom has higher revenue and earnings than Cardiovascular Systems. Cardiovascular Systems is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.Risk & VolatilityCardiovascular Systems has a beta of 1.19, indicating that its share price is 19% more volatile than the S&P 500. Comparatively, DexCom has a beta of 0.86, indicating that its share ...
3/22/2021 CSI Boosts Support Catheter Line with New Acquisition MDDI CSI Boosts Support Catheter Line with New Acquisition magicmine - stock.adobe.com The St. Paul, MN-based company is set to acquire peripheral support catheters from WavePoint Medical. Cardiovascular Systems said it will introduce the acquired catheters as its new ViperCross line in the first half of its fiscal year ending June 30, 2022. MDDI Staff Mar 22, 2021Cardiovascular Systems (CSI) said it has acquired a line of peripheral support catheters ...
3/22/2021 Other news to note for March 22, 2021 | 22 BioWorld Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 7D Surgical, Biocorp Production, Cardiovascular Systems , Diabeloop, Genesis Medtech, Health Logic Interactive, Innotech Precision Medicine, Seaspine, Shockwave Medical, Wavepoint Medical ...
3/18/2021 Analysts Are Bullish on Top Healthcare Stocks: Baxter International (BAX), Avadel Pharmaceuticals (AVDL) analystratings.com ... Kalia is a 4-star analyst with an average return of 10.9% and a 56.3% success rate. Kalia covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Inspire Medical Systems, and Cardiovascular Systems .The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Baxter International with a $89.17 average price target, implying a 12.7% upside from current levels. In a report issued ...
3/17/2021 Cardiovascular Systems, Inc. (NASDAQ:CSII) Shares Acquired by Skandinaviska Enskilda Banken AB publ Dakota Financial News Cardiovascular Systems, Inc. (NASDAQ:CSII) Shares Acquired by Skandinaviska Enskilda Banken AB publ Posted by Adam MastersSkandinaviska Enskilda Banken AB publ lifted its holdings in shares of Cardiovascular Systems , Inc. (NASDAQ:CSII) by 47.8% during the 4th quarter, Holdings Channel.com reports. The fund owned 31,088 shares of the medical device company’s stock after buying an additional 10,054 shares during the period. Skandinaviska Enskilda Banken AB publ’s holdings ...
3/17/2021 Oppenheimer Issues a Buy Rating on Cardiovascular Systems (CSII) analystratings.com Oppenheimer Issues a Buy Rating on Cardiovascular Systems (CSII) Jason Carr - March 17, 2021, 12:25 AM EDT SHARE ON:Oppenheimer analyst Suraj Kalia assigned a Buy rating to Cardiovascular Systems ( CSII ) today and set a price target of $48.00 $40.97.According to TipRanks.com , Kalia is a 4-star 10.3% and a 56.0% success rate. Kalia covers the Healthcare Tactile Systems Technology, Inspire Medical Systems, and Irhythm Technologies. Moderate Buy analyst ...
3/17/2021 Oppenheimer Gives a Buy Rating to Cryolife (CRY) markets.co ... Kalia is a 4-star analyst with an average return of 10.3% and a 56.0% success rate. Kalia covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Inspire Medical Systems, and Cardiovascular Systems .The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Cryolife with a $31.00 average price target.Cryolife’s market cap is currently $952.1M and has a P/E ...
3/17/2021 Oppenheimer Issues a Buy Rating on Tactile Systems Technology (TCMD) markets.co ... 51.32.According to TipRanks.com , Kalia is a 4-star analyst with an average return of 10.3% and a 56.0% success rate. Kalia covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Cardiovascular Systems , and Irhythm Technologies.The word on The Street in general, suggests a Strong Buy analyst consensus rating for Tactile Systems Technology with a $63.25 average price target.Based on Tactile Systems Technology’s latest ...
3/10/2021 Inspire Medical Systems (INSP) Receives a Hold from Oppenheimer markets.co ... 205.99.According to TipRanks.com , Kalia is a 4-star analyst with an average return of 9.0% and a 55.0% success rate. Kalia covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Cardiovascular Systems , and Edwards Lifesciences.Currently, the analyst consensus on Inspire Medical Systems is a Moderate Buy with an average price target of $249.50.See today’s analyst top recommended stocks
Based on Inspire Medical Systems ...
3/8/2021 Brokerages Expect Cardiovascular Systems, Inc. (NASDAQ:CSII) Will Announce Earnings of -$0.10 Per Share Dakota Financial News Brokerages expect Cardiovascular Systems, Inc. (NASDAQ:CSII) to post earnings per share (EPS) of ($0.10) for the current quarter, Zacks reports. Six analysts have provided estimates for Cardiovascular Systems’ earnings. The lowest EPS estimate is ($0.13) and the highest is ($0.05). Cardiovascular Systems reported earnings of ($0.08) per share during the same quarter last year, which indicates a negative year-over-year growth rate of 25%. The business is ...
3/8/2021 Cardiovascular Systems, Inc. (NASDAQ:CSII) Expected to Post Quarterly Sales of $63.43 Million The Markets Daily Cardiovascular Systems, Inc. (NASDAQ:CSII) Expected to Post Quarterly Sales of $63.43 Million Posted by Danessa LincolnWall Street brokerages expect that Cardiovascular Systems , Inc. (NASDAQ:CSII) will post $63.43 million in sales for the current quarter, according to Zacks Investment Research . Six analysts have provided estimates for Cardiovascular Systems ’ earnings. The highest sales estimate is $65.00 million and the lowest is $62.00 million. Cardiovascular Systems reported sales of ...
3/8/2021 Cardiovascular Systems, Inc. (NASDAQ:CSII) Expected to Announce Quarterly Sales of $63.43 Million dispatchtribunal.com Equities research analysts expect Cardiovascular Systems , Inc. (NASDAQ:CSII) to post sales of $63.43 million for the current fiscal quarter, Zacks Investment Research reports. Six analysts have provided estimates for Cardiovascular Systems ’ earnings. The highest sales estimate is $65.00 million and the lowest is $62.00 million. Cardiovascular Systems posted sales of $61.18 million during the same quarter last year, which would indicate a positive year-over-year growth rate ...
3/7/2021 State Board of Administration of Florida Retirement System Decreases Stock Holdings in Cardiovascular Systems, Inc. (NASDAQ:CSII) zolmax.com State Board of Administration of Florida Retirement System Decreases Stock Holdings in Cardiovascular Systems, Inc. (NASDAQ:CSII) Posted by John PerryState Board of Administration of Florida Retirement System trimmed its position in shares of Cardiovascular Systems, Inc. (NASDAQ:CSII) by 2.7% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 23,412 shares of the medical device company’s stock ...
3/1/2021 Analysts Are Bullish on These Healthcare Stocks: Rhythm Pharmaceuticals (RYTM), Strata Skin Sciences (SSKN) markets.co ... Buy rating to Strata Skin Sciences, with a price target of $5.00 $1.90. Kalia is a 4- 10.0% and a 56.2% success rate. Kalia covers the Healthcare Tactile Systems Technology, Inspire Medical Systems, and Cardiovascular Systems .Strata Skin Sciences has an analyst consensus of Moderate Buy, with a price target consensus of $4.00 ...
3/1/2021 Oppenheimer Keeps a Hold Rating on Irhythm Technologies (IRTC) markets.co ... Suraj Kalia maintained a Hold rating on Irhythm Technologies ( IRTC ) today. $154.00. Kalia is a 4-star 10.0% and a 56.2% success rate. Kalia covers the Healthcare Tactile Systems Technology, Inspire Medical Systems, and Cardiovascular Systems .Irhythm Technologies has an analyst consensus of Moderate Buy, with a price target consensus of $216.60, a 34.2% upside from current levels. In a report issued on February 26, Needham also maintained a Hold ...
2/26/2021 Analysts Offer Insights on Healthcare Companies: ICU Medical (ICUI), Acceleron Pharma (XLRN) and Intellia Therapeutics (NTLA) markets.co ... Äôs shares closed last Thursday at $218.19. Bedford is a 5-star analyst with an average return of 16.3% and a 72.6% success rate. Bedford covers the Healthcare sector, focusing on stocks such as Cardiovascular Systems , Merit Medical Systems, and Edwards Lifesciences.Currently, the analyst consensus on ICU Medical is a Moderate Buy with an average price target of $240.50.See today‚Äôs analyst top recommended stocks
Acceleron Pharma (XLRN ...
2/24/2021 Medtronic (MDT) Receives a Hold from Leerink Partners markets.co ... price target of $129.00 $119.01, close to its 52-week high of $120.53. Antalffy is a 5-star analyst with an average return of 29.8% and a 69.4% success rate. Antalffy covers the Healthcare Cardiovascular Systems , Edwards Lifesciences, and Johnson & Johnson.The word on The Street in general, suggests a Strong Buy analyst consensus rating for Medtronic with a $132.35 averageMedtronic’s market cap is currently $158.8B and has ...